| Code | Description | Claims | Beneficiaries | Total Paid |
| 99215 |
Prolong outpt/office vis |
3,647 |
3,264 |
$216K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,721 |
4,192 |
$206K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,607 |
2,229 |
$71K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
466 |
433 |
$6K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
297 |
227 |
$6K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
119 |
105 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
183 |
106 |
$5K |
| 90688 |
|
296 |
279 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
102 |
85 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
42 |
37 |
$2K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
312 |
238 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,017 |
972 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
19 |
14 |
$927.00 |
| 90715 |
|
28 |
27 |
$874.64 |
| 0011A |
|
18 |
14 |
$482.04 |
| 90756 |
|
24 |
22 |
$460.75 |
| 0012A |
|
13 |
12 |
$407.88 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
14 |
$297.96 |
| 80305 |
|
28 |
27 |
$233.48 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
26 |
12 |
$210.00 |
| 90686 |
|
16 |
15 |
$190.30 |
| 96160 |
|
40 |
32 |
$52.50 |
| 91301 |
|
60 |
56 |
$0.00 |
| 91300 |
|
13 |
12 |
$0.00 |